Oludare ('Dare) Odumosu, MPH, PhD, is the CEO of Zelira Therapeutics, a global cannabinoid research and development company that made history with the world's first successful Phase 1/2a clinical trials for a cannabis-based insomnia medicine. Zelira has developed and commercialized cannabinoid formulations focused on insomnia, autism, chronic pain, Parkinson's, and more. At age 37, he became one of the youngest black CEOs of a publicly traded global cannabinoid biopharmaceutical company.
Patrick F. O'Donnell is an author, ghostwriter, content writer, copy editor, and proofreader with more than 30 years of both journalism and marketing industry experience.